CDKN2B-AS1 and hepatocellular carcinoma: LncRNA CDKN2BAS promoted hepatocellular carcinoma metastasis by regulating the miR-153-5p/ARHGAP18 signaling and predicted the poor prognosis in HCC patients 27.